References
1. World, Health, Organization. WHO Handbook for guideline development. 2nd ed. Switzerland (Geneva)2014.
2. CENETEC. CENETEC difusión 2018. Available from: http://cenetec-difusion.com/gpc-sns/.
3. Wollersheim H. Beyond the evidence of guidelines. The Netherlands journal of medicine. 2009;67(2):39-40.
4. Agree., Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Quality & safety in health care. 2003;12(1):18-23.
5. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting, and evaluation in health care. Preventive medicine. 2010;51(5):421-4.
6. Dans AL, Dans LF. Appraising a tool for guideline appraisal (the AGREE II instrument). Journal of clinical epidemiology. 2010;63(12):1281-2.
7. GRADE, Working, Group. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) 2004 - 2018 [01/21/2019]. Available from: http://www.gradeworkinggroup.org/.
8. Group TGW. GRADE handbook for grading quality of evidence and strength of recommendations. Schünemann H BJ, Guyatt G, Oxman A, editor2013 (Updated October).
9. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. Journal of clinical epidemiology. 2011;64(4):383-94.
10. Zhang Y, Akl EA, Schünemann HJ. Using systematic reviews in guideline development: The GRADE approach. Research Synthesis Methods [Internet]. 2018. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/jrsm.1313.
11. Poblano-Verastegui O, Vieyra-Romero WI, Galvan-Garcia AF, Fernandez-Elorriaga M, Rodriguez-Martinez AI, Saturno-Hernandez PJ. [Quality and compliance with Clinical Practice Guidelines of Chronic Noncommunicable Diseases in primary care]. Salud publica de Mexico. 2017;59(2):165-75.
12. Leyva De Los Ríos CD P-GG, Izabal Delgado DE, Coronado Araujo J, Rodríguez Páez IV, Rodríguez Lizárraga JD. Use of Cochrane Evidence in Mexican clinical practice guidelines Gloval Evidence Summit Using Evidence Improving lives; Cope Town, South Afríca2017.
13. Epidat. programa para análisis epidemiológico de datos. Versión 4.2. Consellería de Sanidade, Xunta de Galicia, España; Organización Panamericana de la Salud (OPS-OMS); Universidad CES, Colombia. 2016.
14. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. Development of the AGREE II, part 1: performance, usefulness and areas for improvement. CMAJ : Canadian Medical Association journal = journal de l’Association medicale canadienne. 2010;182(10):1045-52.
15. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. Development of the AGREE II, part 2: assessment of validity of items and tools to support application. CMAJ : Canadian Medical Association journal = journal de l’Association medicale canadienne. 2010;182(10):E472-8.
16. J L. eulerr: Area-Proportional Euler and Venn Diagrams with Ellipses. R package version 5.1.0,. 2019.
17. Cabrera PA, Pardo R. Review of evidence based clinical practice guidelines developed in Latin America and Caribbean during the last decade: an analysis of the methods for grading quality of evidence and topic prioritization. Globalization and health. 2019;15(1):14.
Tables